Global Female Stress Urinary Incontinence Treatment Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Female Stress Urinary Incontinence Treatment Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Female Stress Urinary Incontinence Treatment Devices are products specifically designed to treat stress urinary incontinence. For example, sling systems, pessaries, artificial urethral sphincter (AUS), injectable urethral fillers.

Market Overview:

The latest research study on the global Female Stress Urinary Incontinence Treatment Devices market finds that the global Female Stress Urinary Incontinence Treatment Devices market reached a value of USD 1236.4 million in 2022. It’s expected that the market will achieve USD 1888.0 million by 2028, exhibiting a CAGR of 7.31% during the forecast period.

Impact of Russia and Ukraine War

The Russian-Ukrainian war has jeopardized the world's economic recovery from the COVID-19 pandemic, and countries around the world are facing many challenges such as inflation, food security, energy security, and supply chain pressures. The Organisation for Economic Co-operation and Development (OECD) forecasts a 1.1 percentage point drop in global growth and a 2.5 percentage point rise in inflation due to the Russian-Ukrainian war.
From the perspective of the female stress urinary incontinence treatment device industry, the Russian-Ukrainian war has led to increased energy costs in production. The Russian-Ukrainian war had an impact on energy supplies. In the context of the global economic recovery, global energy prices will show an upward trend in the second half of 2021, driven by increased demand, and the Russian-Ukrainian war has caused world oil prices to rise again. Russia is the third largest oil producer in the world. Russia supplies more than 20 percent of continental Europe's oil. Some European countries mainly depend on Russia for oil imports. The Russian-Ukrainian war had an impact on the oil supply chain, which in turn affected the energy supply in the European region. Rising world oil prices have resulted in increased energy consumption costs for the production and transportation of the female stress urinary incontinence treatment devices industry.
In addition, the Russian-Ukrainian war had a huge impact on global supply chains, hindering the flow of goods, exacerbating dramatic cost increases and product shortages, and causing catastrophic food shortages across the globe.

Strength

The downstream market demand is large. The female stress urinary incontinence treatment device is used to treat female stress urinary incontinence. There are many reasons for female stress urinary incontinence, such as pregnancy, menopause and other reasons. However, women's pregnancy and menopause are things that women will experience at a certain age, and women have a greater demand for female stress urinary incontinence treatment.

Weakness

The production requirements of female stress urinary incontinence treatment devices are relatively high. For the medical device industry, governments of various countries have very high production requirements for the production of products in this industry. Medical device manufacturing can only enter the market with products that ensure safety, and each medical device must pass regional and international compliance standards to ensure the quality and availability of materials and equipment.

Opportunities

Advances in the treatment of female stress urinary incontinence. With the improvement of social living standards, people's demand for health care has increased. At present, the global medical level is constantly improving, and the clinical trials for the treatment of female stress urinary incontinence are constantly progressing. With the advancement of female stress urinary incontinence treatment methods and the popularization of female stress urinary incontinence treatment, the downstream market will increase the demand for female stress urinary incontinence treatment devices.

Threat

Shipping costs go up. Under the influence of the epidemic and the Russian-Ukrainian war, there has been an energy crisis in the world, and energy has risen, causing the industry's transportation costs to rise. In the female stress urinary incontinence treatment device industry, manufacturers need to purchase raw materials, and the raw materials need transportation costs; in addition, product sales need to ship the products to the corresponding downstream customers, and product transportation costs are required in the process. Therefore, rising energy prices have led to rising transportation costs in the Female Stress Urinary Incontinence Treatment Devices industry.

Region Overview:

In 2022, the share of the Female Stress Urinary Incontinence Treatment Devices market in North America stood at 44.48%.

Company Overview:

Boston Scientific is one of the major players operating in the Female Stress Urinary Incontinence Treatment Devices market, holding a share of 22.32% in 2022.

Boston Scientific

Endoscopy, Interventionalm Cardiology, Neuromodulation, Peripheral Interventions, Rhythm Management, Urology and Pelvic Health.

Johnson & Johnson

Pharmaceuticals, Healthcare and Medical Devices.

Coloplast

Ostomy Care, Continence Care, Wound & Skin Care and Interventional Urology.

Segmentation Overview:

As for product types, the Sling Systems segment held the largest market share in 2022.

Sling Systems

The Sling System is a pubis-mounted urethral stabilization and support system for the long-term cure of recurrent female urinary incontinence. A sling is a soft mesh placed inside the body.

Injectable Urethral Bulking Agents

Injectable Urethral Bulking Agents can be composed of synthetic materials or substances such as bovine collagen that are injected into the urethral wall to help close the urethra, thereby improving the ability of the sphincter to close.

Pessary

Pessaries are shaped like a ring with two bumps on each side of the urethra, and are fitted and placed in place by a doctor or nurse. This device helps support the bottom of the patient's bladder to prevent urine leakage during exercise, especially if the bladder is prolapsed. Pessaries need to be removed and cleaned regularly. Pessaries are mainly used in patients with pelvic organ prolapse.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global Female Stress Urinary Incontinence Treatment Devices market covered in Chapter 3:

MedGyn Products
Axonics
CooperSurgical
Coloplast
Obgyn Medical Technology
Cousin Surgery
B. Braun
Boston Scientific
Johnson & Johnson
A.M.I. GmbH
Caldera Medical

In Chapter 4 and Chapter 14.2, on the basis of types, the Female Stress Urinary Incontinence Treatment Devices market from 2018 to 2029 is primarily split into:

Sling Systems
Injectable Urethral Bulking Agents
Pessary
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Female Stress Urinary Incontinence Treatment Devices market from 2018 to 2029 covers:

Gynecology Clinic
Ambulatory Surgical Centers
Hospitals

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)